MARSHALL WACE, LLP - ITEOS THERAPEUTICS INC ownership

ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 120 filers reported holding ITEOS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of ITEOS THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$469,080
-37.3%
35,429
-35.6%
0.00%
-50.0%
Q1 2023$748,673
-85.0%
55,009
-64.6%
0.00%
-77.8%
Q1 2022$5,001,000
-50.5%
155,373
-28.3%
0.01%
-52.6%
Q4 2021$10,096,000
+561.2%
216,822
+283.4%
0.02%
+216.7%
Q3 2021$1,527,000
-58.3%
56,557
-60.4%
0.01%
-64.7%
Q2 2021$3,666,000142,9290.02%
Other shareholders
ITEOS THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,738,785$52,174,00019.87%
MPM BioImpact LLC 1,745,943$33,260,0007.88%
Boxer Capital, LLC 2,154,058$41,035,0002.31%
TANG CAPITAL MANAGEMENT LLC 937,500$17,859,0002.19%
RA Capital Management 4,417,259$84,149,0001.80%
BVF INC/IL 1,810,835$34,496,0001.42%
Zebra Capital Management LLC 12,271$234,0000.89%
Integral Health Asset Management, LLC 195,000$3,715,0000.72%
Prairiewood Capital, LLC 32,269$615,0000.51%
DAFNA Capital Management LLC 97,560$1,859,0000.50%
View complete list of ITEOS THERAPEUTICS INC shareholders